Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
Xin Zhong,1,2 Ming-Yan Liu,1,2 Miao He,1,2 Ke Du,1,2 Min-Jie Wei1,2 1Department of Pharmacology, School of Pharmacy, China Medical University, 2Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Shenyang, Liaoning Province, People’s Republic of China...
Guardado en:
Autores principales: | Zhong X, Liu M, He M, Du K, Wei M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/888ff44648dc4dffb02e6d89eab5f70c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Variabilidad y variantesde la enfermedad de Alzheimer
por: Donoso S,Archibaldo, et al.
Publicado: (2005) -
Effects of ApoE genotype on clinical phenotypes in early‐onset and late‐onset Alzheimer's disease in China: Data from the PUMCH dementia cohort
por: Liling Dong, et al.
Publicado: (2021) -
INTERLEUKIN 33 AND FIBROSIS: PATHOGENESIS UPDATED
por: E. G. Uchasova, et al.
Publicado: (2018) -
Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
por: Cheng D, et al.
Publicado: (2014) -
11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
por: Youn YC, et al.
Publicado: (2017)